These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 31210561

  • 1. Development and evaluation of candidate subunit vaccine and novel antitoxin against botulinum neurotoxin serotype E.
    Shi DY, Liu FJ, Mao YY, Cui RT, Lu JS, Yu YZ, Dong XJ, Yang ZX, Sun ZW, Pang XB.
    Hum Vaccin Immunother; 2020; 16(1):100-108. PubMed ID: 31210561
    [Abstract] [Full Text] [Related]

  • 2. Development and evaluation of candidate vaccine and antitoxin against botulinum neurotoxin serotype F.
    Yu YZ, Zhang SM, Ma Y, Zhu HQ, Wang WB, Du Y, Zhou XW, Wang RL, Wang S, Yu WY, Huang PT, Sun ZW.
    Clin Immunol; 2010 Nov; 137(2):271-80. PubMed ID: 20696619
    [Abstract] [Full Text] [Related]

  • 3. Development and evaluation of candidate subunit vaccine against botulinum neurotoxin serotype B.
    Shi DY, Chen BY, Mao YY, Zhou G, Lu JS, Yu YZ, Zhou XW, Sun ZW.
    Hum Vaccin Immunother; 2019 Nov; 15(3):755-760. PubMed ID: 30433836
    [Abstract] [Full Text] [Related]

  • 4. Development and preclinical evaluation of a new F(ab')₂ antitoxin against botulinum neurotoxin serotype A.
    Yu YZ, Zhang SM, Wang WB, Du Y, Zhu HQ, Wang RL, Zhou XW, Lin JB, Wang S, Yu WY, Huang PT, Sun ZW.
    Biochimie; 2010 Oct; 92(10):1315-20. PubMed ID: 20600570
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evaluation of a recombinant Hc of Clostridium botulinum neurotoxin serotype F as an effective subunit vaccine.
    Yu YZ, Li N, Wang RL, Zhu HQ, Wang S, Yu WY, Sun ZW.
    Clin Vaccine Immunol; 2008 Dec; 15(12):1819-23. PubMed ID: 18845829
    [Abstract] [Full Text] [Related]

  • 7. Protective potential of recombinant non-purified botulinum neurotoxin serotypes C and D.
    Moreira C, da Cunha CE, Moreira GM, Mendonça M, Salvarani FM, Moreira ÂN, Conceição FR.
    Anaerobe; 2016 Aug; 40():58-62. PubMed ID: 27236078
    [Abstract] [Full Text] [Related]

  • 8. Production and evaluation of a recombinant subunit vaccine against botulinum neurotoxin serotype B using a 293E expression system.
    Yu Y, Shi D, Liu S, Gong ZW, Wang S, Sun Z.
    Hum Vaccin Immunother; 2015 Aug; 11(2):468-73. PubMed ID: 25483668
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Recombinant Botulinum Neurotoxin Hc Subunit (BoNT Hc) and Catalytically Inactive Clostridium botulinum Holoproteins (ciBoNT HPs) as Vaccine Candidates for the Prevention of Botulism.
    Webb RP, Smith TJ, Smith LA, Wright PM, Guernieri RL, Brown JL, Skerry JC.
    Toxins (Basel); 2017 Sep 03; 9(9):. PubMed ID: 28869522
    [Abstract] [Full Text] [Related]

  • 12. Pentavalent replicon vaccines against botulinum neurotoxins and tetanus toxin using DNA-based Semliki Forest virus replicon vectors.
    Yu YZ, Liu S, Ma Y, Gong ZW, Wang S, Sun ZW.
    Hum Vaccin Immunother; 2014 Sep 03; 10(7):1874-9. PubMed ID: 25424795
    [Abstract] [Full Text] [Related]

  • 13. Production and evaluation of a recombinant chimeric vaccine against clostridium botulinum neurotoxin types C and D.
    Gil LA, da Cunha CE, Moreira GM, Salvarani FM, Assis RA, Lobato FC, Mendonça M, Dellagostin OA, Conceição FR.
    PLoS One; 2013 Sep 03; 8(7):e69692. PubMed ID: 23936080
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Alternative vaccination against equine botulism (BoNT/C).
    Frey J, Eberle S, Stahl C, Mazuet C, Popoff M, Schatzmann E, Gerber V, Dungu B, Straub R.
    Equine Vet J; 2007 Nov 03; 39(6):516-20. PubMed ID: 18065309
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immune response of horses to vaccination with the recombinant Hc domain of botulinum neurotoxin types C and D.
    Stahl C, Unger L, Mazuet C, Popoff M, Straub R, Frey J.
    Vaccine; 2009 Sep 18; 27(41):5661-6. PubMed ID: 19646409
    [Abstract] [Full Text] [Related]

  • 18. Rapid immune responses to a botulinum neurotoxin Hc subunit vaccine through in vivo targeting to antigen-presenting cells.
    White DM, Pellett S, Jensen MA, Tepp WH, Johnson EA, Arnason BG.
    Infect Immun; 2011 Aug 18; 79(8):3388-96. PubMed ID: 21576339
    [Abstract] [Full Text] [Related]

  • 19. Safety and immunogenicity of investigational recombinant botulinum vaccine, rBV A/B, in volunteers with pre-existing botulinum toxoid immunity.
    Khouri JM, Motter RN, Arnon SS.
    Vaccine; 2018 Apr 05; 36(15):2041-2048. PubMed ID: 29475762
    [Abstract] [Full Text] [Related]

  • 20. Enhancing toxin-based vaccines against botulism.
    Przedpelski A, Tepp WH, Zuverink M, Johnson EA, Pellet S, Barbieri JT.
    Vaccine; 2018 Feb 01; 36(6):827-832. PubMed ID: 29307477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.